PTK2 and cancer: Due to early studies revealing that FAK acts as strong contributor to the cancer hallmarks in various human cancers, it was activated by integrins; interaction with paxillin resulted in focal adhesion formation and cytoskeleton remodeling promoted tumor invasion and metastasis [37,38,39].